@CaReMeUK

CaReMeUK is a collaboration between national societies to form a Cardio-Renal-Metabolic partnership to improve outcomes in heart, kidney disease and diabetes.

Joined September 2021
  • Tweets10
  • Following35
  • Followers31
1Media
Semaglutide for CVD Great to see the new NICE draft guidance released today for semaglutide in people with CVD and overweight/obesity. nice.org.uk/guidance/gid-ta1… Work is now needed to enable implementation to reduce the risk of future CV events in these individuals
16
Breaking news Introducing the first pragmatic CVD residual risk reduction guideline in the UK. A game changer in addressing CV risk beyond LDL-C, this pathway from a multidisciplinary team in Yorkshire gives practical advice on tackling metabolic, inflammatory, & thrombotic risk
2
4
1
4
804
Elevate your CV prevention game Passionate about CVD prevention? Join the new CVR3 working group to shape the future of care for generations. Contact [email protected] to join the CaReMe UK network #CVD #lipids #triglycerides #diabetes #renal
1
131
Breaking news from Novo Nordisk. In the randomized, double-blind SELECT trial, semaglutide 2.4 mg as an adjunct to standard of care reduced MACE by 20% in 17,604 adults with established CVD with overweight or obesity and without prior history of diabetes. Let's wait for the NNT.
5
58
6
170
25,653
Not every day you see an anti-obesity drug that has an average of >24% body weight loss 🆕 @NEJM #ADA2023 nejm.org/doi/full/10.1056/NE… Triple receptor agonist weight loss exceeds prior GLP-1 drugs (and dual receptor agents) and has yet to plateau
30
272
38
1,179
473,610
Are you working in Primary Care and have involvement in the referrals process to Lipid Clinics? We've created a survey to undertake a brief analysis of current referrals processes to Lipid Clinics in West Yorkshire. Help fill out our survey today: ow.ly/fakF50Kt3kZ
2
1
Updated NICE guideline on obesity published today. nice.org.uk/guidance/cg189/c…
A short message to all with #Diabetes about the NICE guidelines released “Or forever hold your peace” 😊 #gbdoc
33
51
19
365
Encouraging data with SGLT2i continue to build in HFpEF. nature.com/articles/s41591-0…
Finally, I have updated my @GPnotebook diabetes & renal shortcut to reflect new licenses/indications! Given complexity of the situation I have split original tool into 2 to reflect glycaemic & extra-glycaemic indicationd All feedback welcome! PDF download gpnotebookeducation.com
9
62
7
187
Load more